Core Insights - The strategic partnership between Kefu and Taobao Flash aims to transform the online pharmaceutical purchasing model and enhance self-health management solutions for consumers [1] Group 1: Partnership Overview - Kefu has over 135 years of experience in the consumer health sector and owns several well-known brands such as Tylenol and Listerine, which are trusted by consumers and professionals alike [1] - The collaboration will leverage Kefu's brand influence and Taobao Flash's platform advantages to expand consumer reach and promote scientific health management concepts [1] Group 2: Focus Areas of Collaboration - The partnership will focus on mutual user growth by integrating Taobao Flash's membership benefits and expanding the potential consumer base [1] - Kefu and Taobao Flash will enhance brand collaboration efforts to achieve sustained mutual benefits [1] Group 3: Technological Integration - Taobao Flash's "AI Find Medicine" service will provide a comprehensive solution from medication selection to purchase, supported by Kefu's extensive knowledge in disease management and medication plans [2] - Kefu will be the first brand to share API data with Taobao Flash, enabling real-time supply monitoring and improving market coverage [2] Group 4: Future Goals - The partnership aims to enhance data sharing and intelligent analysis to predict stock shortages and ensure the availability of health products [2] - Both companies are committed to providing high-quality health products and self-diagnosis services to a broader consumer base [2]

Core Insights - The company reported significant growth in both revenue and profit for the fiscal year 2024, with total revenue reaching 1.766 billion yuan, a year-on-year increase of 29.26%, and net profit attributable to shareholders at 106 million yuan, up 94.58% [1] - In Q1 2025, the company continued its growth trajectory, achieving revenue of 574 million yuan, a 54.16% increase year-on-year, and a net profit of 27.42 million yuan, up 113.88% [1] Business Performance - The company's self-owned brand business generated revenue of 501 million yuan in 2024, marking a 90.28% increase and accounting for 28.37% of total revenue [1] - The brand "Zhanjia" has shown exceptional growth, with its total sales doubling year-on-year across multiple channels, including Tmall, Douyin, and Xiaohongshu, with GMV growth exceeding 100% [1] - The newly launched health brand "FineNutri" has rapidly gained traction, ranking second in Tmall's oral beauty nutrition category and first in the health supplement store heat ranking as of March 2025 [2] Strategic Partnerships and Initiatives - The company signed strategic cooperation agreements with several international brands, including Amorepacific's "Meishangxuan" and DHC, to enhance its presence in the health and personal care sectors [3] - The company has also partnered with Norwegian company ZoocaCalanus for exclusive distribution of a key ingredient in Greater China and established a strategic investment collaboration with AI ingredient development firm MetaNovas [2] Operational Efficiency - The company's agency operation business generated revenue of 764 million yuan in 2024, with an overall gross margin improvement of nearly 5 percentage points compared to the previous year [3] - During the Double Eleven shopping festival, nearly 50 agency-operated stores saw significant GMV growth, with multiple partner stores ranking in the top 5 of their categories [3] Market Performance - The company's stock has been well-received in the market, closing at 51.4 yuan per share on April 24, 2024, reflecting a 5.7% increase, and a year-to-date gain of over 84%, bringing its total market capitalization to 8.4 billion yuan [3]

Core Viewpoint - The establishment of the Kefu Beijing R&D Center is expected to attract more high-quality cosmetics companies to Beijing, enhancing the development of the cosmetics industry in the region [1] Industry Summary - The cosmetics industry in Beijing is experiencing a positive development trend, with continuous improvement in high-quality development levels [1] - The Beijing Municipal Drug Administration is optimizing regulatory measures and the business environment to support the growth of the beauty economy [1] - The establishment of the Kefu Beijing R&D Center injects new vitality into the industry and serves as a demonstration effect for attracting more excellent cosmetics companies to Beijing [1] Company Summary - The Kefu Beijing R&D Center is located within the Beijing Dabao Cosmetics Co., Ltd. park and aims to provide R&D, registration, and medical support for multiple skincare brands under Kefu, including Dabao and Aveeno [1] - The center is collaborating with Kefu's scientific research networks in Shanghai and Xi'an to leverage global research resources and accelerate the introduction of new products [1] - Ongoing academic projects at the center include research on skin cell mitochondria in collaboration with Peking University's School of Life Sciences and global skin health research [1]